Potential Biomarkers for Filovirus Vaccine Efficacy

Information

• Research Project
• 8290192

• ApplicationId

  8290192

• Core Project Number

  Y1AI0671-2-0-1

• Full Project Number

  Y1AI0671-2-0-1

• Serial Number

  671

• FOA Number

• Sub Project Id

• Project Start Date

  -

• Project End Date

  -

• Program Officer Name

• Budget Start Date

  -

• Budget End Date

  -

• Fiscal Year

  2011

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• National Institute of Allergy and Infectious Diseases (NIAID)

This IAA supports the studies to assess the expression and biological activity among the twelve subtypes of IFN-alpha and three subtypes of IFN-Iambda with the goal of showing that expression patterns of IFNalpha and IFN-Iambda will serve as a rapid marker for protective vaccination against Ebola and other filovirus infections.

IC Name

• Activity

  Y01

• Administering IC

  AI

• Application Type

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  100000

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  855

• Ed Inst. Type

• Funding ICs

  NIAID:100000\

• Funding Mechanism

  Contracts, Extramural

• Study Section

• Study Section Name

• Organization Name

  NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

• Organization Department

• Organization DUNS

• Organization City

• Organization State

• Organization Country

• Organization Zip Code

• Organization District